Literature DB >> 17456836

Utility of the clinical dementia rating in Asian populations.

Wee Shiong Lim1, Mei Sian Chong, Suresh Sahadevan.   

Abstract

Consistent with the worldwide demographic trend of population aging, dementia is expected to become a burgeoning public health problem in Asian populations. Thus, there is a pressing need for reliable and valid methods of dementia diagnosis and staging that are applicable in heterogeneous Asian populations. The Clinical Dementia Rating (CDR) is an informant-based global assessment scale with established reliability and validity that has been widely utilized as a severity-ranking scale in many studies of Asian populations. From a diagnostic standpoint, the CDR is congruent with the Diagnostic and Statistical Manual of Mental Disorders approach of dementia diagnosis. It exhibits excellent discriminatory ability in the very mild stages of dementia, a useful property that is germane to the surging interest in mild cognitive impairment and related concepts. Limitations of the CDR include its length of administration, reliance on clinical judgment and collateral source information, and relative insensitivity as a measure of change in interventional studies. Since the exercise of clinical judgment is inherent in scoring, CDR raters should be mindful of the influence of cultural factors on premorbid lifestyle, informant reliability and performance in certain CDR test items (especially those pertaining to the categories of judgment and problem solving, community, and home and hobbies). Thus, in future studies that involve the nascent use of the CDR in Asian populations, it is recommended that any transcultural adaptation of CDR items be described in detail and appropriate validation studies be carried out before adopting the CDR as a yardstick measure of assessment. The potential of adapted versions of the CDR in chronic care settings and advanced cases should be explored. An integrative approach, combining brief informant interview in conjunction with brief objective cognitive testing, could be a viable strategy for dementia screening in the clinical and research setting that warrants further evaluation in Asian populations.

Entities:  

Mesh:

Year:  2007        PMID: 17456836      PMCID: PMC1855342          DOI: 10.3121/cmr.2007.693

Source DB:  PubMed          Journal:  Clin Med Res        ISSN: 1539-4182


  80 in total

1.  The reliability and validity of the Alzheimer's Disease Assessment Scale Cognitive Subscale (ADAS-Cog) among the elderly Chinese in Hong Kong.

Authors:  L W Chu; K C Chiu; S L Hui; G K Yu; W J Tsui; P W Lee
Journal:  Ann Acad Med Singapore       Date:  2000-07       Impact factor: 2.473

2.  Prevalence estimation of dementia among Thai elderly: a national survey.

Authors:  S Jitapunkul; C Kunanusont; W Phoolcharoen; P Suriyawongpaisal
Journal:  J Med Assoc Thai       Date:  2001-04

Review 3.  The magnitude of dementia occurrence in the world.

Authors:  Anders Wimo; Bengt Winblad; Hedda Aguero-Torres; Eva von Strauss
Journal:  Alzheimer Dis Assoc Disord       Date:  2003 Apr-Jun       Impact factor: 2.703

4.  The three-item clock-drawing test: a simplified screening test for Alzheimer's disease.

Authors:  Ker-Neng Lin; Pei-Ning Wang; Chien Chen; Yu-Hong Chiu; Chi-Chung Kuo; Ya-Yun Chuang; Hsiu-Chih Liu
Journal:  Eur Neurol       Date:  2003       Impact factor: 1.710

5.  Retrospective postmortem dementia assessment. Validation of a new clinical interview to assist neuropathologic study.

Authors:  P B Davis; H White; J L Price; D McKeel; L N Robins
Journal:  Arch Neurol       Date:  1991-06

6.  Cutoff scores of the cognitive abilities screening instrument, Chinese version in screening of dementia.

Authors:  Ker-Neng Lin; Pei-Ning Wang; Chia-Yih Liu; Wei-Ta Chen; Yi-Chung Lee; Hsiu-Chih Liu
Journal:  Dement Geriatr Cogn Disord       Date:  2002       Impact factor: 2.959

7.  Different MRI findings for normal elderly and very mild Alzheimer's disease in a community: implications for clinical practice the Tajiri Project.

Authors:  Hiroshi Ishii; Kenichi Meguro; Satoshi Yamaguchi; Kazumi Hirayama; Michio Tabuchi; Etsuro Mori; Atsushi Yamadori
Journal:  Arch Gerontol Geriatr       Date:  2005-08-08       Impact factor: 3.250

8.  Detection and staging of dementia in Alzheimer's disease. Use of the neuropsychological measures developed for the Consortium to Establish a Registry for Alzheimer's Disease.

Authors:  K A Welsh; N Butters; J P Hughes; R C Mohs; A Heyman
Journal:  Arch Neurol       Date:  1992-05

9.  Incidence of Alzheimer's disease in a rural community in India: the Indo-US study.

Authors:  V Chandra; R Pandav; H H Dodge; J M Johnston; S H Belle; S T DeKosky; M Ganguli
Journal:  Neurology       Date:  2001-09-25       Impact factor: 9.910

10.  Prevalence of dementia in a semi-urban population in Sri Lanka: report from a regional survey.

Authors:  H A de Silva; S B Gunatilake; A D Smith
Journal:  Int J Geriatr Psychiatry       Date:  2003-08       Impact factor: 3.485

View more
  30 in total

1.  Diagnosis and staging of mild cognitive impairment, using a modification of the clinical dementia rating scale: the mCDR.

Authors:  Ranjan Duara; David A Loewenstein; Maria T Greig-Custo; Ashok Raj; Warren Barker; Elizabeth Potter; Elizabeth Schofield; Brent Small; John Schinka; Yougui Wu; Huntington Potter
Journal:  Int J Geriatr Psychiatry       Date:  2010-03       Impact factor: 3.485

Review 2.  Legal medicine: assessing mental capacity and writing medical reports for deputy applications.

Authors:  Hui Min Lim; Lee Gan Goh; T Thirumoorthy
Journal:  Singapore Med J       Date:  2016-10-18       Impact factor: 1.858

3.  Neuropsychiatric Symptoms and Risk Factors in Mild Cognitive Impairment: A Cohort Investigation of Elderly Patients.

Authors:  A-N Yang; X-L Wang; H-R Rui; H Luo; M Pang; X-M Dou
Journal:  J Nutr Health Aging       Date:  2020       Impact factor: 4.075

4.  Plasma biomarker profiles and the correlation with cognitive function across the clinical spectrum of Alzheimer's disease.

Authors:  Zhenxu Xiao; Xue Wu; Wanqing Wu; Jingwei Yi; Xiaoniu Liang; Saineng Ding; Li Zheng; Jianfeng Luo; Hongchen Gu; Qianhua Zhao; Hong Xu; Ding Ding
Journal:  Alzheimers Res Ther       Date:  2021-07-05       Impact factor: 6.982

5.  Frontal Assessment Battery in Early Cognitive Impairment: Psychometric Property and Factor Structure.

Authors:  W Y Goh; D Chan; N B Ali; A P Chew; A Chuo; M Chan; W S Lim
Journal:  J Nutr Health Aging       Date:  2019       Impact factor: 4.075

6.  TOMM40 and APOE variants synergistically increase the risk of Alzheimer's disease in a Chinese population.

Authors:  Zheng Zhu; Yang Yang; Zhenxu Xiao; Qianhua Zhao; Wanqing Wu; Xiaoniu Liang; Jianfeng Luo; Yang Cao; Minhua Shao; Qihao Guo; Ding Ding
Journal:  Aging Clin Exp Res       Date:  2020-07-28       Impact factor: 3.636

7.  The Effect of Lipoic Acid Therapy on Cognitive Functioning in Patients with Alzheimer's Disease.

Authors:  Antonietta Fava; Domenico Pirritano; Massimiliano Plastino; Dario Cristiano; Giovanna Puccio; Carmen Colica; Caterina Ermio; Matteo De Bartolo; Gaetano Mauro; Domenico Bosco
Journal:  J Neurodegener Dis       Date:  2013-03-30

8.  Association between tooth loss and cognitive function among 3063 Chinese older adults: a community-based study.

Authors:  Jianfeng Luo; Bei Wu; Qianhua Zhao; Qihao Guo; Haijiao Meng; Lirong Yu; Li Zheng; Zhen Hong; Ding Ding
Journal:  PLoS One       Date:  2015-03-24       Impact factor: 3.240

9.  Yizhi Xingnao prescription improves the cognitive function of patients after a transient ischemic attack.

Authors:  Donglin Jiang; Xing Chu; Lingling Hu; Shengyang Jiang; Feng Hu; Junming Sun; Chengwan Li
Journal:  Neural Regen Res       Date:  2012-02-25       Impact factor: 5.135

10.  Reliability and Validity of the Clinical Dementia Rating for Community-Living Elderly Subjects without an Informant.

Authors:  Ma Shwe Zin Nyunt; Mei Sian Chong; Wee Shiong Lim; Tih Shih Lee; Philip Yap; Tze Pin Ng
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2013-10-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.